A carregar...
Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III Studies
BACKGROUND. Evaluation of adverse events (AEs) in pivotal registration trials and ongoing postmarketing surveillance is important for all biologics, including biosimilars. A combined analysis of two pivotal registration studies was performed to strengthen evidence on safety for biosimilar filgrastim...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896710/ https://ncbi.nlm.nih.gov/pubmed/29317553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0348 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|